They also admitted that it was impossible to identify whether a low concentration of PON1 is involved in the pathogenesis of NAFLD or one of the effects of NAFLD is the reduction in the concentration of PON1. This evidence concerns the gene PON1 and metabolic dysfunction-associated steatotic liver disease.